SPIA
RGN

Steward Partners Investment Advisory’s REGENERX BIOPHARMACEUTICALS RGN Stock Holding History

Steward Partners Investment Advisory’s Portfolio RGN Stock Details RGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-300
Closed – – 3520
2021
Q2 		$0 Buy
+300
New – ﹤0.01% 7615

Other funds holding RGN

WJWM
Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return

Steward Partners Investment Advisory's RGN Position: Q3 2021 in Review

Steward Partners Investment Advisory sold out of REGENERX BIOPHARMACEUTICALS (RGN) in Q3 2021, closing a stake of 300 shares.

Steward Partners Investment Advisory first reported a position in RGN in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 1 fund tracked by Wall St. Rank holds RGN as of Q3 2021.

  • Steward Partners Investment Advisory reported no remaining REGENERX BIOPHARMACEUTICALS position as of Q3 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 300 REGENERX BIOPHARMACEUTICALS shares in Q3 2021.
  • Steward Partners Investment Advisory first reported a position in REGENERX BIOPHARMACEUTICALS in Q2 2021 and held it in 1 quarter.
  • Steward Partners Investment Advisory's REGENERX BIOPHARMACEUTICALS position peaked at $0 in Q2 2021.
  • 1 fund tracked by Wall St. Rank held REGENERX BIOPHARMACEUTICALS as of Q3 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2021, filed 12 Nov 2021.